Massachusetts Wealth Management’s Eli Lilly LLY Stock Holding History
Bought
Maintained
Sold
Other funds holding LLY
VCM
VPM
Massachusetts Wealth Management's LLY Position: Q1 2026 in Review
Massachusetts Wealth Management increased its Eli Lilly (LLY) stake by 1.7% in Q1 2026, buying an estimated $50.7K and bringing the position to 3,000 shares worth $2.76M. The position accounts for 1.2% of the portfolio, ranked #29.
Massachusetts Wealth Management first reported a position in LLY in Q2 2023 and has held it in 12 quarters since. The position peaked at $3.17M in Q4 2025. 4,353 funds tracked by Wall St. Rank hold LLY as of Q1 2026.
- Massachusetts Wealth Management held 3,000 shares of Eli Lilly worth $2.76M as of Q1 2026.
- Massachusetts Wealth Management bought 50 Eli Lilly shares in Q1 2026, an estimated $50.7K.
- Eli Lilly made up 1.2% of Massachusetts Wealth Management's portfolio in Q1 2026, its #29 holding.
- Massachusetts Wealth Management first reported a position in Eli Lilly in Q2 2023 and has held it in 12 quarters since.
- Massachusetts Wealth Management's Eli Lilly position peaked at $3.17M in Q4 2025.
- 4,353 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.
Based on Massachusetts Wealth Management's 13F filing for Q1 2026, filed 15 Apr 2026.